budesonide
NDC 68682-309, budesonide, tablet, extended release, from Oceanside Pharmaceuticals.
- Product NDC
- 68682-309
- Status
- Listed
- Labeler
- Oceanside Pharmaceuticals
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA203634
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68682-309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BUDESONIDE9 mg/1
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68682-309-30 | 68682030930 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68682-309-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a12b2e99-c8b3-4d08-9af0-8c4a4376ebf1
Use it
Look up 68682-309 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68682-309 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68682-309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.